BTMD
biote Corp
1.20$
-5.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.4% | 15.2% | 15.8% | 20.2% | 30.3% | 24.8% | 13.2% | 14.5% | 29.3% | 16.3% | 8.7% | -2.7% | 13.3% | |
| 0.9% | 3.3% | 1.6% | 1.8% | 1.6% | 2.3% | 1.7% | 1.9% | 2.0% | 2.0% | 2.2% | 2.2% | 2.1% | |
| 4.9% | 4.4% | 3.8% | 5.8% | 4.4% | 3.8% | 4.3% | 4.5% | 5.0% | 4.7% | 3.9% | 8.4% | 5.5% | |
| -11.7% | -9.2% | -4.3% | 2.5% | 4.2% | 16.8% | -9.6% | -9.5% | 6.5% | -4.1% | 4.6% | 3.6% | 2.6% | |
| 1.1% | 2.2% | 2.3% | 5.8% | 3.8% | 2.2% | 3.3% | 3.7% | 1.4% | 2.3% | 2.6% | 4.0% | 2.6% | |
| -1.1% | 41.6% | -26.0% | -6.8% | -3.8% | -2.6% | -3.8% | -4.0% | -1.4% | -5.1% | -2.6% | -5.9% | -3.7% | |
| 2.2% | 2.4% | 0.2% | 8.4% | 8.2% | 0.2% | 1.4% | 1.8% | 0.0% | 0.3% | 0.9% | 0.9% | 0.5% | |
| 0.0% | 0.9% | -8.7% | -3.1% | 0.0% | 0.0% | 0.0% | 0.0% | -7.0% | 0.0% | -2.4% | -10.8% | -5.0% | |
| – | – | – | – | -3.0% | -23.2% | -3.2% | -3.2% | -3.3% | 7.4% | -3.5% | 41.7% | 10.2% | |
| -5.6% | -5.5% | -11.6% | -119.9% | -3.4% | -19.9% | -4.6% | -55.7% | -10.3% | -19.7% | -47.9% | 21.8% | -14.1% | |
| -6.4% | 51.3% | -21.8% | -106.5% | 23.0% | 2.2% | 4.8% | -45.2% | 17.6% | -8.5% | -41.8% | 13.2% | -4.6% | |
| -0.7% | 13.0% | 13.5% | 14.4% | 26.4% | 22.7% | 9.9% | 10.8% | 27.9% | 14.0% | 6.1% | -6.6% | 10.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.